Former Teva president joins Sun Pharma
June 7, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing
Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …
ABPI ‘fears for future of UK research’ ahead of pricing talks
June 7, 2012Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP
The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …
Havas buys digital experts Creative Lynx
June 6, 2012Medical Communications Creative Lynx, Havas, Havas Health
Havas has acquired a majority stake in Creative Lynx, one of the leading digital health communications agency in Europe. Creative …
Shire makes two senior appointments
June 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Colpman, Judge, Shire
Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm. Colpman, …
Global marketing access strategy: local activation
June 6, 2012Business Services, Medical Communications, Sales and Marketing Global marketing, MSI, market access
Pharma has historically been an industry that likes to put things in boxes, neatly organising different aspects of commercialisation into …
William Kaelin Jr elected to Lilly board
June 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly
Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …
Merck Serono staff may strike over Geneva HQ closure
June 6, 2012Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D
Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …
Herceptin successor impresses at ASCO
June 6, 2012Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1
Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …
AMRI wins new contract for rehabilitated facility
June 6, 2012Manufacturing and Production AMRI, Carduium Therapeutics, FDA, Taylor
Albany Molecular Research Inc (AMRI) has won a contract to fill a newly-approved product into sterile syringes at its facility …
Catalent exits commercial packaging business
June 1, 2012Manufacturing and Production Catalent, Frazier Healthcare
Catalent Pharma Solutions has decided to sell its US-based commercial packaging business to private equity group Frazier Healthcare. Catalent said …
Boehringer seeks NHS partners for COPD campaign
June 1, 2012Medical Communications, Sales and Marketing Boehringer, COPD, disease awareness campaign
Boehringer is seeking NHS partners for its COPD campaign: ‘Know it. Check it. Treat it.’ The campaign aims to raise …
BMS establishes cancer vaccine network
June 1, 2012Research and Development, Sales and Marketing
Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …
ROCK medical communications appoints two new account managers
June 1, 2012Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment
ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …
Boehringer appoints new executive director of Consumer Healthcare Marketing
May 31, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim
Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division. In …
Vertex admits blunder over drug data
May 31, 2012Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis
Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …
HGS shareholder challenges ‘poison pill’
May 31, 2012Sales and Marketing Benlysta, GSK, HGS, hostile bid
The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …
UK doctors vote to strike
May 30, 2012Medical Communications BMA, GPs, NHS, UK government, doctors, strike
Doctors will take industrial action for the first time in almost 40 years, the British Medical Association has confirmed. The …
Europe’s CMO market set to double by 2018, says F&S
May 30, 2012Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing
The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …
Pharma relieved as Senate backs FDA fees
May 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing FDA, PDUFA, PhRMA, US
The US Senate has approved a law that will continue to allow pharma firms to help fund the FDA. The …
Photo story: GSK’s 2012 legacy
May 30, 2012Research and Development Andrew Witty, GSK, Olympics 2012
Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
